Increased Survival After Long-Term Treatment With Mibefradil, a Selective T-Channel Calcium Antagonist, in Heart Failure

This publication has 30 references indexed in Scilit:

• Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension.
  Hypertension, 1994
• Aggravation of left ventricular dilatation and reduction of survival by a calcium channel blocker in rats with chronic myocardial infarction
  American Heart Journal, 1993
• The angiotensin AT₂ receptor modulates T‐type calcium current in non‐differentiated NG108‐15 cells
  FEBS Letters, 1992
• Antihypertensive effect of felodipine associated with persistent sympathetic activation and minimal regression of left ventricular hypertrophy
  The American Journal of Cardiology, 1992
• The structurally novel Ca2+ channel blocker Ro 40-5967, which binds to the [3H] desmethoxyverapamil receptor, is devoid of the negative inotropic effects of verapamil in normal and failing rat hearts
  Cardiovascular Drugs and Therapy, 1990
• Effects of arterial vasodilators on cardiac hypertrophy and sympathetic activity in rats.
  Hypertension, 1988
• Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril.
  Circulation, 1985
• Effects of diltiazem on cardiac function and regional blood flow at rest and during exercise in a conscious rat preparation of chronic heart failure (myocardial infarction).
  Circulation, 1985
• Coronary haemodynamic effects of nifedipine. Comparison with glyceryl trinitrate.
  Heart, 1983
• Calcium-channel blockers: Pharmacologic considerations
  American Heart Journal, 1982